Carol Doss

924 total citations
8 papers, 811 citations indexed

About

Carol Doss is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy. According to data from OpenAlex, Carol Doss has authored 8 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology and Allergy. Recurrent topics in Carol Doss's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Cell Adhesion Molecules Research (4 papers) and Immunotherapy and Immune Responses (3 papers). Carol Doss is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Cell Adhesion Molecules Research (4 papers) and Immunotherapy and Immune Responses (3 papers). Carol Doss collaborates with scholars based in United States, Hungary and Finland. Carol Doss's co-authors include Ronald Levy, Shoshana Levy, Rachel Oren, S Takahashi, E. GRONOWICZ, Shingo Takahashi, Shuji Takahashi, Jim Schröder, Roger A. Warnke and J Bindl and has published in prestigious journals such as The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

Carol Doss

8 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol Doss United States 8 406 289 276 241 106 8 811
M A Ursa Spain 6 394 1.0× 230 0.8× 138 0.5× 380 1.6× 103 1.0× 6 780
Robert M. J. Keehnen Netherlands 11 407 1.0× 323 1.1× 78 0.3× 182 0.8× 124 1.2× 15 890
Makoto Haino Japan 11 326 0.8× 302 1.0× 242 0.9× 72 0.3× 91 0.9× 15 709
Carmela Kantor Finland 11 230 0.6× 410 1.4× 197 0.7× 383 1.6× 219 2.1× 14 891
Z Steplewski United States 17 502 1.2× 678 2.3× 654 2.4× 134 0.6× 444 4.2× 30 1.3k
David Zhou United States 4 300 0.7× 415 1.4× 134 0.5× 377 1.6× 108 1.0× 6 855
Ajay Shrivastava United States 8 165 0.4× 670 2.3× 110 0.4× 314 1.3× 231 2.2× 10 1.1k
Fiorella Petronzelli Italy 18 391 1.0× 480 1.7× 200 0.7× 49 0.2× 252 2.4× 41 1.2k
Jean E. Maguire United States 13 397 1.0× 405 1.4× 101 0.4× 130 0.5× 91 0.9× 16 807
Ann S. Miller United States 9 1.0k 2.5× 424 1.5× 200 0.7× 204 0.8× 177 1.7× 10 1.3k

Countries citing papers authored by Carol Doss

Since Specialization
Citations

This map shows the geographic impact of Carol Doss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Doss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Doss more than expected).

Fields of papers citing papers by Carol Doss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Doss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Doss. The network helps show where Carol Doss may publish in the future.

Co-authorship network of co-authors of Carol Doss

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Doss. A scholar is included among the top collaborators of Carol Doss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Doss. Carol Doss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Takahashi, Shingo, Carol Doss, Shoshana Levy, & Ronald Levy. (1990). TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen.. The Journal of Immunology. 145(7). 2207–2213. 126 indexed citations
2.
Oren, Rachel, S Takahashi, Carol Doss, Ronald Levy, & Shoshana Levy. (1990). TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins.. Molecular and Cellular Biology. 10(8). 4007–4015. 323 indexed citations
3.
Oren, Rachel, Shuji Takahashi, Carol Doss, Ronald Levy, & Shoshana Levy. (1990). TAPA-1, the Target of an Antiproliferative Antibody, Defines a New Family of Transmembrane Proteins. Molecular and Cellular Biology. 10(8). 4007–4015. 121 indexed citations
4.
Link, Michael P., J Bindl, T C Meeker, et al.. (1986). A unique antigen on mature B cells defined by a monoclonal antibody.. The Journal of Immunology. 137(9). 3013–3018. 42 indexed citations
5.
Thielemans, K, David G. Maloney, T C Meeker, et al.. (1984). Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas.. The Journal of Immunology. 133(1). 495–501. 60 indexed citations
6.
GRONOWICZ, E., Carol Doss, F. D. Howard, D. C. Morrison, & S Strober. (1980). An in vitro line of the B cell tumor BCL1 can be activated by LPS to secrete IgM1.. The Journal of Immunology. 125(3). 976–980. 50 indexed citations
7.
GRONOWICZ, E., Carol Doss, & Jim Schröder. (1979). Activation to IgG Secretion by Lipopolysaccharide Requires Several Proliferation Cycles. The Journal of Immunology. 123(5). 2057–2062. 45 indexed citations
8.
GRONOWICZ, E., et al.. (1979). Surface Ig Isotypes on Cells Responding to Lipopolysaccharide by IgM and IgG Secretion. The Journal of Immunology. 123(5). 2049–2056. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026